BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 15911979)

  • 1. Flow cytometric measurement of functional and phenotypic P-glycoprotein.
    Pallis M; Das-Gupta E
    Methods Mol Med; 2005; 111():167-81. PubMed ID: 15911979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
    Lu C; Hassan HT
    Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discrepant flow cytometric expression and function of P-glycoprotein in neuroblastic tumors.
    De Moerloose B; Dhooge C; Laureys G; Benoit Y; Demarche M; Devalck C; Plantaz D; Leroy J; Philippé J
    Cytometry; 1999 Oct; 37(2):125-32. PubMed ID: 10486524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclosporine diminishes multidrug resistance in K562/ADM cells and improves complete remission in patients with acute myeloid leukemia.
    Li GY; Liu JZ; Zhang B; Wang LX; Wang CB; Chen SG
    Biomed Pharmacother; 2009 Sep; 63(8):566-70. PubMed ID: 19095404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leukemic blast and natural killer cell P-glycoprotein function and inhibition in a clinical trial of zosuquidar infusion in acute myeloid leukemia.
    Marcelletti JF; Multani PS; Lancet JE; Baer MR; Sikic BI
    Leuk Res; 2009 Jun; 33(6):769-74. PubMed ID: 18976810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of residual neuroblastoma cells in bone marrow: comparison of flow cytometry with immunocytochemistry.
    Swerts K; De Moerloose B; Dhooge C; Brichard B; Benoit Y; Laureys G; Philippé J
    Cytometry B Clin Cytom; 2004 Sep; 61(1):9-19. PubMed ID: 15351977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional multidrug resistance in acute myeloblastic leukaemia: a standardized flow cytometric assay for intracellular daunorubicin accumulation.
    Pallis M; Russell NH
    Br J Haematol; 1998 Jan; 100(1):194-7. PubMed ID: 9450811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential influences of leukemia-specific and genetic factors on p-glycoprotein expression in blasts from 817 patients entered into the National Cancer Research Network acute myeloid leukemia 14 and 15 trials.
    Seedhouse CH; Grundy M; White P; Li Y; Fisher J; Yakunina D; Moorman AV; Hoy T; Russell N; Burnett A; Pallis M;
    Clin Cancer Res; 2007 Dec; 13(23):7059-66. PubMed ID: 18056183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A phase I trial of continuous infusion of the multidrug resistance inhibitor zosuquidar with daunorubicin and cytarabine in acute myeloid leukemia.
    Lancet JE; Baer MR; Duran GE; List AF; Fielding R; Marcelletti JF; Multani PS; Sikic BI
    Leuk Res; 2009 Aug; 33(8):1055-61. PubMed ID: 19108889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased malignant behavior in neuroblastoma cells with acquired multi-drug resistance does not depend on P-gp expression.
    Kotchetkov R; Driever PH; Cinatl J; Michaelis M; Karaskova J; Blaheta R; Squire JA; Von Deimling A; Moog J; Cinatl J
    Int J Oncol; 2005 Oct; 27(4):1029-37. PubMed ID: 16142320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. JC-1, a sensitive probe for a simultaneous detection of P-glycoprotein activity and apoptosis in leukemic cells.
    Chaoui D; Faussat AM; Majdak P; Tang R; Perrot JY; Pasco S; Klein C; Marie JP; Legrand O
    Cytometry B Clin Cytom; 2006 May; 70(3):189-96. PubMed ID: 16568474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of p-glycoprotein-mediated multidrug resistance by macrocyclic bisbibenzyl derivatives in adriamycin-resistant human myelogenous leukemia (K562/A02) cells.
    Li X; Sun B; Zhu CJ; Yuan HQ; Shi YQ; Gao J; Li SJ; Lou HX
    Toxicol In Vitro; 2009 Feb; 23(1):29-36. PubMed ID: 18938236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Flurazepam inhibits the P-glycoprotein transport function: an insight to revert multidrug-resistance phenotype.
    Lima SA; Tavares J; Gameiro P; de Castro B; Cordeiro-da-Silva A
    Eur J Pharmacol; 2008 Feb; 581(1-2):30-6. PubMed ID: 18190907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reversal effect of isotetrandrine, an isoquinoline alkaloid extracted from Caulis Mahoniae, on P-glycoprotein-mediated doxorubicin-resistance in human breast cancer (MCF-7/DOX) cells.
    Wang TX; Yang XH
    Yao Xue Xue Bao; 2008 May; 43(5):461-6. PubMed ID: 18717331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flow cytometric assay of modulation of P-glycoprotein function in whole blood by the multidrug resistance inhibitor GG918.
    Witherspoon SM; Emerson DL; Kerr BM; Lloyd TL; Dalton WS; Wissel PS
    Clin Cancer Res; 1996 Jan; 2(1):7-12. PubMed ID: 9816083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multidrug resistance phenotype evaluation by immunofluorescence and functional tests: comparison of two monoclonal antibodies and three fluorescent dyes in three cells lines.
    Maynadie M; Lizard G; Solary E; Roignot P; Carli PM
    Anticancer Res; 1994; 14(6B):2605-9. PubMed ID: 7872688
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of two functional flow cytometric assays to assess P-gp activity in acute leukemia.
    Swerts K; de Moerloose B; Dhooge C; Noens L; Laureys G; Benoit Y; Philippé J
    Leuk Lymphoma; 2004 Nov; 45(11):2221-8. PubMed ID: 15512810
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of tetrandrine as a potential-reversing agent with daunorubicin, etoposide and cytarabine for the treatment of refractory and relapsed acute myelogenous leukemia.
    Xu WL; Shen HL; Ao ZF; Chen BA; Xia W; Gao F; Zhang YN
    Leuk Res; 2006 Apr; 30(4):407-13. PubMed ID: 16219352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel multiparameter flow cytometry assay using Syto16 for the simultaneous detection of early apoptosis and apoptosis-corrected P-glycoprotein function in clinical samples.
    van der Pol MA; Broxterman HJ; Westra G; Ossenkoppele GJ; Schuurhuis GJ
    Cytometry B Clin Cytom; 2003 Sep; 55(1):14-21. PubMed ID: 12949955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinoline derivative KB3-1 potentiates paclitaxel induced cytotoxicity and cycle arrest via multidrug resistance reversal in MES-SA/DX5 cancer cells.
    Koo JS; Choi WC; Rhee YH; Lee HJ; Lee EO; Ahn KS; Bae HS; Ahn KS; Kang JM; Choi SU; Kim MO; Lu J; Kim SH
    Life Sci; 2008 Nov; 83(21-22):700-8. PubMed ID: 18845169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.